Experts from the Standing Committee on Vaccination (Stiko) of Robert Koch Institute of Virology in Germany advised not to administer a vaccine from the British-Swedish pharmaceutical company AstraZeneca to people over 65.
The experts have confirmed that the drug can be given to people aged 18 to 64 years. However, there is not enough evidence that it will be effective for people over the age of 65.
The European Medicines Agency (EMA) will decide on the use of AstraZeneca vaccine on January 29, notes Deutsche Welle. It is now being actively used in a vaccination campaign in Great Britain, including for the elderly.
In January it was reported that AstraZeneca would not be able to supply the expected number of doses of its vaccine to Europe. According to the German newspaper Bild, then one of the reasons for the supply disruption was a fire at a vaccine production plant under construction in the Indian city of Pune.